Cogent Biosciences announces creation of Cogent Research Team

Cogent Biosciences announces creation of Cogent Research Team

BOULDER and CAMBRIDGE, Mass. -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the formation... Read More

Monday April 12, 2021 0 comments Tags: Boulder, Cogent Biosciences, John Robinson, Andrew Robbins